Efecto de la variante Ómicron sobre la incidencia y la letalidad durante la 6.ª onda epidémica COVID-19 en España(Pag.-e 102073)

  1. A. Serrano-Cumplido
  2. A. Ruíz-García 1
  3. A. del Rio-Herrero 2
  4. P.B. Antón-Eguía 3
  5. R.M. Micó-Pérez 4
  6. A. Calderón-Montero 5
  7. E. Romero-Rodríguez 6
  8. A. Segura-Fragoso 7
  9. V. Martín-Sánchez 8
  1. 1 Centro de Salud Universitario Pinto, Universidad Europea de Madrid, Pinto, Madrid, España
  2. 2 Hospital Alto Deba, Osakidetza, Arrasate, Guipúzcoa, España
  3. 3 Hospital de Manacor, Manacor, Islas Baleares, España
  4. 4 Centro de Salud Fontanars dels Alforins, Fontanars dels Alforins, Valencia, España
  5. 5 Consorcio de Investigación Biomédica en Epidemiología y Salud Pública (CIBERESP), Madrid, España
  6. 6 Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, España
  7. 7 Universidad de Castilla-La Mancha, Talavera de la Reina, Toledo, España
  8. 8 Universidad de León
    info

    Universidad de León

    León, España

    ROR https://ror.org/02tzt0b78

Mostrar afiliaciones +
Revista:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Año de publicación: 2024

Número: 2

Páginas: 8-8

Tipo: Artículo

DOI: 10.1016/J.SEMERG.2023.102073 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Semergen: revista española de medicina de familia

Resumen

La pandemia COVID-19 ha puesto a prueba los sistemas sanitarios a nivel mundial. Las sucesivas ondas epidémicas han mostrado características diferentes. La variante Ómicron del SARS-CoV-2 modificó el comportamiento epidémico que habían seguido las variantes previas. El objetivo de este análisis fue determinar las características epidemiológicas de la COVID-19 durante la 6.ª onda epidémica y sus diferencias según predominara las variantes Delta u Ómicron. Se analizaron los datos epidemiológicos correspondientes a la 6.ª onda epidémica publicados por los organismos oficiales, y se analizaron la incidencia acumulada de infección (IA-I) y las tasas de letalidad (TL), tanto del conjunto de España como de las diferentes Comunidades Autónomas, en el conjunto de la población y por grupos etarios. Los resultados mostraron que la IA-I era mayor con la variante Ómicron (10,89 vs. 0,75% con Delta) mientras que la TL lo era con la variante Delta (4,2 vs. 1,3‰ con Ómicron), así como una mayor tasa de hospitalización e ingreso en UCI con la variante Delta.

Referencias bibliográficas

  • F.P. Lyngse, L.H. Mortensen, M.J. Denwood, L.E. Christiansen, C.H. Møller, R.L. Skov, et al. SARS-CoV-2 Omicron VOC Transmission in Danish Households medRxiv (2021), 10.1101/2021.12.27.21268278 View article Google Scholar
  • F.P. Lyngse, C.T. Kirkeby, M. Denwood, L.E. Christiansen, K. Mølbak, C.H. Møller, et al. Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Household medRxiv (2022), 10.1101/2022.01.28.22270044 View article Google Scholar
  • N. Garrett, A. Tapley, J. Andriesen, I. Seocharan, L.H. Fisher, L. Bunts, et al. High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron medRxiv (2021), 10.1101/2021.12.20.21268130 View article Google Scholar
  • T.R. Pak, C. Rhee, R. Wang, M. Klompas Discontinuation of Universal Admission Testing for SARS-CoV-2 and Hospital-Onset COVID-19 Infections in England and Scotland JAMA Intern Med (2023), pp. E1-E3, 10.1001/jamainternmed.2023.1261 View PDF This article is free to access. Google Scholar
  • A. Ruiz-García, F. Vitelli-Storelli, A. Serrano-Cumplido, A. Segura-Fragoso, A. Calderón-Montero, V. Martín-Sánchez Tasas de letalidad por SARS-CoV-2 durante la segunda onda epidémica en España según Comunidades Autónomas Semergen (2022), 10.1016/j.semerg.2022.02.004 View article Google Scholar
  • F. Vitelli-Storelli, V. Martín-Sánchez, A. Ruíz-García, A. Serrano-Cumplido, R. Micó-Pérez, A. Barquilla-García Case-fatality rate of SARS-CoV-2 infection during the third and fifth epidemic waves in Spain: Impact of vaccination Semergen (2023), 10.1016/j.semerg.2023.102026 View PDF Your institution provides access to this article. Google Scholar
  • A.C. Ulloa, S.A. Buchan, N. Daneman, K.A. Brown Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada JAMA (2022), 10.1001/jama.2022.2274 View PDF This article is free to access. Google Scholar
  • F. Abdullah, J. Myers, D. Basu, G. Tintinger, V. Ueckermann, M. Mathebula, et al. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, South Africa Int J Infect Dis, 116 (2022), pp. 38-42, 10.1016/j.ijid.2021.12.357 View PDFView articleView in ScopusGoogle Scholar
  • S.A. Madhi, G. Kwatra, J.E. Myers, W. Jassat, N. Dhar, C.K. Mukendi, et al. Population Immunity and Covid-19 Severity with Omicron Variant in South Africa N Engl J Med, 386 (2022), pp. 1314-1326, 10.1056/NEJMoa2119658 View articleView in ScopusGoogle Scholar
  • Y. Araf, F. Akter, Y. Tang, R. Fatemi, S.A. Parvez, C. Zheng, et al. Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines J Med Virol, 94 (2022), pp. 1825-1832, 10.1002/jmv.27588 View PDF Your institution provides access to this article. View in ScopusGoogle Scholar
  • Y. Liu, J. Rocklöv The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta J Travel Med, 29 (2022), pp. 1-4, 10.1093/jtm/taac037 View PDF This article is free to access. Google Scholar
  • Y. Liu, J. Rocklöv The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus J Travel Med, 28 (2021), pp. 1-3, 10.1093/jtm/taab124 View PDF This article is free to access. Google Scholar
  • K. Ito, C. Piantham, H. Nishiura Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark J Med Virol, 94 (2022), pp. 2265-2268, 10.1002/jmv.27560 View PDF This article is free to access. View in ScopusGoogle Scholar
  • N. Wolter, W. Jassat, S. Walaza, R. Welch, H. Moultrie, M. Groome, et al. Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa medRxiv (2021), 10.1101/2021.12.21.21268116 View article Google Scholar
  • C. Maslo, R. Friedland, M. Toubkin, A. Laubscher, T. Akaloo, B. Kama Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves JAMA (2021), 10.1001/jama.2021.24868 View PDF This article is free to access. Google Scholar
  • M.-A. Davies, R. Kassanjee, P. Rosseau, E. Morden, L. Johnson, W. Solomon, et al. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province South Africa medRxiv. (2022), 10.1101/2022.01.12.22269148 View article Google Scholar
  • L. Wang, N.A. Berger, D.C. Kaelber, P.B. Davis, N.D. Volkow, R. Xu Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US JAMA Pediatrics (2022), 10.1001/jamapediatrics.2022.0945 View PDF This article is free to access. Google Scholar
  • V. Hall, S. Foulkes, F. Insalata, P. Kirwan, A. Saei, A. Atti, et al. Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection N Engl J Med (2022), 10.1056/NEJMoa2118691 View article Google Scholar
  • C. Maslo, R. Friedland, M. Toubkin, A. Laubscher, T. Akaloo, B. Kama Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves JAMA (2021), 10.1001/jama.2021.24868 View PDF This article is free to access. Google Scholar
  • N. Wolter, W. Jassat, S. Walaza, R. Welch, H. Moultrie, M. Groome, et al. Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa medRxiv (2021), 10.1101/2021.12.21.21268116 View article Google Scholar
  • N. Wolter, W. Jassat, DATCOV-Gen, A. von Gottberg, C. Cohen Clinical severity of Omicron sub-lineage BA.2 compared to BA.1 in South Africa medRxiv (2022), 10.1101/2022.02.17.22271030 View article Google Scholar
  • S. Collie, J. Nayager, L. Bamford, L.-G. Bekker, M. Zylstra, G. Gray Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa N Engl J Med, 387 (2022), pp. 1332-1333, 10.1056/NEJMc2210093 View articleView in ScopusGoogle Scholar
Fuente de los datos: Dialnet